Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

July 01, 1996; Volume 50,Issue 1
  • You have access
    Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
    A Schrammel, S Behrends, K Schmidt, D Koesling and B Mayer
    Molecular Pharmacology July 1996, 50 (1) 1-5;
  • You have access
    (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.
    C Thomsen, V Bruno, F Nicoletti, M Marinozzi and R Pellicciari
    Molecular Pharmacology July 1996, 50 (1) 6-9;
  • You have access
    Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.
    J L Barwick, L C Quattrochi, A S Mills, C Potenza, R H Tukey and P S Guzelian
    Molecular Pharmacology July 1996, 50 (1) 10-16;
  • You have access
    Effect of phorbol myristate acetate on alpha 1-adrenergic action in cells expressing recombinant alpha 1-adrenoceptor subtypes.
    J Vázquez-Prado and J A García-Sáinz
    Molecular Pharmacology July 1996, 50 (1) 17-22;
  • You have access
    Alpha 6 and gamma 2 subunit antisense oligodeoxynucleotides alter gamma-aminobutyric acid receptor pharmacology in cerebellar granule neurons.
    W J Zhu, J F Wang, S Vicini and D R Grayson
    Molecular Pharmacology July 1996, 50 (1) 23-33;
  • You have access
    Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    N Almaula, B J Ebersole, J A Ballesteros, H Weinstein and S C Sealfon
    Molecular Pharmacology July 1996, 50 (1) 34-42;
  • You have access
    mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
    M Yoshimura, H Ikeda and B Tabakoff
    Molecular Pharmacology July 1996, 50 (1) 43-51;
  • You have access
    Bimodal distribution of renal cytochrome P450 3A activity in humans.
    B D Haehner, J C Gorski, M Vandenbranden, S A Wrighton, S K Janardan, P B Watkins and S D Hall
    Molecular Pharmacology July 1996, 50 (1) 52-59;
  • You have access
    Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
    S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
    Molecular Pharmacology July 1996, 50 (1) 60-66;
  • You have access
    Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
    J M Peters, Y C Zhou, P A Ram, S S Lee, F J Gonzalez and D J Waxman
    Molecular Pharmacology July 1996, 50 (1) 67-74;
  • You have access
    Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.
    F Mesange, F Delarue, J Puel, F Bayard and J C Faye
    Molecular Pharmacology July 1996, 50 (1) 75-79;
  • You have access
    k-Opioid receptor activation of a dendrotoxin-sensitive potassium channel mediates presynaptic inhibition of mossy fiber neurotransmitter release.
    M L Simmons and C Chavkin
    Molecular Pharmacology July 1996, 50 (1) 80-85;
  • You have access
    KINFIT II: a nonlinear least-squares program for analysis of kinetic binding data.
    G E Rovati, R Shrager, S Nicosia and P J Munson
    Molecular Pharmacology July 1996, 50 (1) 86-95;
  • You have access
    Genetic evidence for involvement of multiple effector systems in alpha 2A-adrenergic receptor inhibition of stimulus-secretion coupling.
    P P Lakhlani, D M Lovinger and L E Limbird
    Molecular Pharmacology July 1996, 50 (1) 96-103;
  • You have access
    Effects of long-term treatment with the allosteric enhancer, PD81,723, on Chinese hamster ovary cells expressing recombinant human A1 adenosine receptors.
    S Bhattacharya and J Linden
    Molecular Pharmacology July 1996, 50 (1) 104-111;
  • You have access
    Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
    D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
    Molecular Pharmacology July 1996, 50 (1) 112-118;
  • You have access
    Properties of recombinant gamma-aminobutyric acid A receptor isoforms containing the alpha 5 subunit subtype.
    E C Burgard, E I Tietz, T R Neelands and R L Macdonald
    Molecular Pharmacology July 1996, 50 (1) 119-127;
  • You have access
    B1 and B2 kinin receptors mediate distinct patterns of intracellular Ca2+ signaling in single cultured vascular smooth muscle cells.
    S A Mathis, N L Criscimagna and L M Leeb-Lundberg
    Molecular Pharmacology July 1996, 50 (1) 128-139;
  • You have access
    Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
    N H Lee, N S Geoghagen, E Cheng, R T Cline and C M Fraser
    Molecular Pharmacology July 1996, 50 (1) 140-148;
  • You have access
    Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
    K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt
    Molecular Pharmacology July 1996, 50 (1) 149-159;
  • You have access
    2',3'-Didehydro-3'-deoxythymidine: regulation of its metabolic activation by modulators of thymidine-5'-triphosphate biosynthesis.
    G S Ahluwalia, W Y Gao, H Mitsuya and D G Johns
    Molecular Pharmacology July 1996, 50 (1) 160-165;
  • You have access
    Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells.
    P A Witt-Enderby and M L Dubocovich
    Molecular Pharmacology July 1996, 50 (1) 166-174;
  • You have access
    Inducible expression of beta 1- and beta 2-adrenergic receptors in rat C6 glioma cells: functional interactions between closely related subtypes.
    H Zhong, S W Guerrero, T A Esbenshade and K P Minneman
    Molecular Pharmacology July 1996, 50 (1) 175-184;
  • You have access
    Enhancement of recombinant alpha 1 beta 1 gamma 2L gamma-aminobutyric acidA receptor whole-cell currents by protein kinase C is mediated through phosphorylation of both beta 1 and gamma 2L subunits.
    Y F Lin, T P Angelotti, E M Dudek, M D Browning and R L Macdonald
    Molecular Pharmacology July 1996, 50 (1) 185-195;
  • You have access
    A novel irreversible antagonist of the A1-adenosine receptor.
    M Srinivas, J C Shryock, P J Scammells, J Ruble, S P Baker and L Belardinelli
    Molecular Pharmacology July 1996, 50 (1) 196-205;
  • You have access
    Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
    V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
    Molecular Pharmacology July 1996, 50 (1) 206-217;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 50, Issue 1
1 Jul 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity
  • P2X7 Positive Modulator Structure-Activity Relationship
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics